Li Chen

Li Chen has extensive experience in biostatistics, having served as Director and subsequently Executive Director of Biostatistics at Amgen since 2004. Key roles included Global Statistical Lead and TA Head for Bone Health and Oncology from 2014 to 2019 and various leadership positions in Early and Clinical Development Biostatistics. Prior to joining Amgen, Li Chen was a Research Faculty member at the University of Minnesota-Twin Cities from 1996 to 2004. Academically, Li Chen holds a Doctor of Science (ScD) in Biostatistics from Harvard University, a PhD in Mechanical Engineering from Tufts University, and a Bachelor of Science from Peking University.